$MEDP · Medpace Holdings, Inc.
Medpace Holdings CEO, President, and 10% owner August J. Troendle reported two open-market sales totaling 48,667 shares for $30,320,929. The transactions were executed at prices between $621.02 and $625.47 per share. No 10b5-1 trading plan was in effect.
- CEO August Troendle sold 48,667 shares for $30,320,929 total across two transactions.
- Sale prices ranged from $621.02 to $625.47 per share.
- No 10b5-1 trading plan was in effect for these sales.
- Troendle remains a 10% owner and holds 338,225 shares after the sales.
- Troendle is President, CEO, Director, and 10% Owner — the most senior insider.
Stock was already down 4.18% in the regular session to $598.08 before this filing hit after-hours. The $30.3M CEO sale — executed without a 10b5-1 plan — adds further selling pressure to an already weak tape.
A $30.3M discretionary sale by the CEO/Chairman/10% owner without a 10b5-1 plan is a high-signal insider transaction that demands investor attention.
_Not applicable._
Discretionary CEO sale of $30.3M with no 10b5-1 plan signals potential lack of confidence; Troendle's dual role as largest shareholder and chief executive concentrates both information and selling power.
Get filings like this before the market reacts.
Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.